Science & Research
Dr. Eliaz and his team partner with renowned institutes including Harvard, Columbia, and others to investigate integrative approaches in the treatment of cancer and chronic conditions. In addition, many of Dr. Eliaz’s unique preparations have been studied independently by third-party groups, with peer-reviewed results demonstrating unparalleled benefits against cancer, fibrotic diseases and more.
The unique form of Modified Citrus Pectin developed by Dr. Eliaz is recognized as the only commercially available galectin-3 blocker, substantiated by more than 75+ published studies in cancer, cardiovascular disease, chronic kidney disease, and other pro-inflammatory, degenerative conditions.
Summaries with links to research abstracts
Survival Paradox Research and Resources
Modified Citrus Pectin Research Only one form of Modified Citrus Pectin has been extensively researched and proven to support our most critical areas of health.
Breast Cancer Research
2017 Preclinical Study: Polybotanical Breast Formula Enhances Tamoxifen in Estrogen Receptor-Positive Human Breast Cancer In Vitro and In Vivo 2012 Preclinical Study: Breast Formula Prevents
Galectin-3 Research
2021 Translational Study: Galectin-3 in septic acute kidney injury: a translational study 2021 Preclinical Study: Galectin-3 participates in PASMC migration and proliferation by interacting with
Honokiol Research
2020 Preclinical Study: Honokiol Ameliorates Pulmonary Fibrosis 2020 Preclinical Study: Honokiol Inhibits Melanoma Growth 2019 Preclinical Study: Antidepressant-like Effects of Honokiol 2019 Review: Anticancer Potential
Medicinal Mushroom Research
2020 Preclinical Study: Antibiofilm and Antimicrobial Activities of Five Mushrooms 2020 Preclinical Study: Cordyceps reduces airway inflammation in treatment of asthma 2020 Preclinical Study: Protective
Modified Citrus Pectin Research
2023 Clinical Study: Final Long-term Results of MCP Treatment in Biochemically Relapsed Prostate Cancer 2021 Clinical Study: Modified Citrus Pectin Reduces PSA and Disease Progression
Prostate Cancer Research
2019 Clinical Study Updated Results: Modified Citrus Pectin Halts Biochemically-Relapsed Prostate Cancer 2018 Clinical Survey: Polybotanical Prostate Formula Shows Improvements in Lower Urinary Tract Symptoms
Heavy Metal Chelation and Detoxification Research
2020 Clinical Study: Polycyclic Aromatic Hydrocarbon Exposure and Cytokine Storms in Preschool Children 2019 Clinical Case Study: Modified Citrus Pectin and Alginate Combo Safely Remove
Cardiovascular and Circulatory Health Research
2020 Clinical Review: Mindfulness Interventions Reduce Blood Pressure 2019 Preclinical Study: Modified Citrus Pectin Improves Ischemic Heart Failure by Downregulating Galectin 3 and Reducing Myocardial
Tibetan Herbal Formula Research
2016 Clinical Review: Tibetan Herbal Preparation Reduces Pain and Increases Walking Distance in Patients with Intermittent Claudication 2015 Review: Tibetan Herbal Preparation within European Framework
